
Overview
Zentiva Polska is a partner to patients, healthcare professionals and the healthcare system. The company develops, manufactures and supplies high-quality, affordable medicines, reaching over 100 million people in more than 40 European countries.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2017-09-04. Active
58 1030 1508 0000 0008 1889 0000
04 1030 1508 0000 0008 1889 0002
31 1030 1508 0000 0008 1889 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 19,095PLN 19,095 |
Secured liabilities
| Type | Creditor | |
|---|---|---|
Registered pledge | – | |
Financial pledge | – |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 14, 2022 | Merger registered | |
| Feb 14, 2022 | Merger registered |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Zentiva Pharma Gmbh | 2,641,950 | $35,682,739.06 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sanofisp. z o.o. | $384,123,246.36 | sanofi.com | ||
| Novartis Polandsp. z o.o. | $378,147,128.47 | novartis.com | ||
| USP Zdrowiesp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| Pfizer Trading Polskasp. z o.o. | $299,067,553.99 | pfizer.pl | ||
| Natur Produkt Zdrovitsp. z o.o. | $205,379,396.79 | zdrovit.pl | ||
| Bialmedsp. z o.o. | $203,238,055.12 | bialmed.pl | ||
| Roche Diagnostics Polskasp. z o.o. | $199,208,461.57 | roche.pl | ||
| Servier Polska Servicessp. z o.o. | $157,143,144.15 | servier.pl | ||
| Medezinsp. z o.o. | $107,559,392.19 | medezin.pl | ||
| Magnapharm Polandsp. z o.o. | $90,512,785.67 | magnapharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2018-07-02 | Share capital change (97,500.00 PLN → 132,097,500.00 PLN) | |
| 2018-04-27 | Address change (Ul. Bonifraterska 17, 02-203, Warszawa → Ul. Bonifraterska 17, 00-203, Warszawa) | |
| 2018-04-17 | Share capital change (5,000.00 PLN → 97,500.00 PLN) | |
| 2018-03-13 | Address change (Aleje Jerozolimskie 56c, 00-803, Warszawa → Ul. Bonifraterska 17, 02-203, Warszawa) | |
| 2018-03-13 | Name change (Ledivia Investments → Zentiva Polska) |
FAQ
Last updated: 2026-10-04